ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,250.50
0.60%
S&P ASX All Technology
3,828.50
0.37%
Brent Oil
76.495
0.00%
US Dollar vs AUD
1.60849
0.00%
Bitcoin
98,172.44
0.07%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AC Immune SA (ACIU)

  7. AC Immune SA (ACIU) News

ACIU

AC Immune (ACIU)

AC Immune SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACIU
DateTimeSourceHeadlineSymbolCompany
19/12/202409:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
14/12/202409:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ACIUAC Immune SA
11/12/202400:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
10/12/202423:00GlobeNewswire Inc.AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndromeNASDAQ:ACIUAC Immune SA
14/11/202423:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
14/11/202423:00GlobeNewswire Inc.AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseNASDAQ:ACIUAC Immune SA
13/11/202423:00GlobeNewswire Inc.AC Immune to Present at the Jefferies 2024 London Healthcare ConferenceNASDAQ:ACIUAC Immune SA
05/11/202423:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
05/11/202423:00GlobeNewswire Inc.AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNASDAQ:ACIUAC Immune SA
28/09/202406:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
20/09/202406:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
19/09/202406:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
17/09/202421:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
28/08/202423:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
07/08/202406:50Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACIUAC Immune SA
07/08/202406:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
06/08/202421:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
01/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACIUAC Immune SA
31/07/202422:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
27/07/202406:53Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:ACIUAC Immune SA
25/07/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
21/05/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
17/05/202404:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
13/05/202420:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
13/05/202420:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
10/02/202408:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACIUAC Immune SA
22/01/202423:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
04/01/202408:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
04/01/202400:10GlobeNewswire Inc.AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseasesNASDAQ:ACIUAC Immune SA
29/12/202308:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
 Showing the most relevant articles for your search:NASDAQ:ACIU

Your Recent History

NASDAQ
AAPL
Apple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
ASX
MQG
Macquarie
NASDAQ
AMZN
Amazon.com
ASX
ORG
Origin Energy
FX
EURAUD
Euro vs AUD
FX
AUDUSD
AUD vs US Dollar
COIN
BTCUSD
Bitcoin
ASX
XFL
S&P ASX 50
NYSE
XOM
Exxon Mobil
NYSE
MCD
McDonalds
FX
GBPAUD
Sterling vs AUD
PM
XAUUSD
Gold vs US Dollar
ASX
XMM
S&P ASX 300 Metals and M...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads